Vanguard Group
BTMD icon

Vanguard Group’s Biote Corp BTMD Stock Holding History

Vanguard Group’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.76M Buy
1,444,733
+17,782
+1% +$48.6K ﹤0.01% 3361
2025
Q3 		$4.28M Buy
1,426,951
+3,368
+0.2% +$12K ﹤0.01% 3329
2025
Q2 		$5.72M Buy
1,423,583
+11,418
+0.8% +$42.1K ﹤0.01% 3164
2025
Q1 		$4.7M Sell
1,412,165
-17,945
-1% -$85.6K ﹤0.01% 3198
2024
Q4 		$8.84M Buy
1,430,110
+12,317
+0.9% +$71.6K ﹤0.01% 3020
2024
Q3 		$7.91M Buy
1,417,793
+36,893
+3% +$246K ﹤0.01% 3069
2024
Q2 		$10.3M Sell
1,380,900
-24,014
-2% -$148K ﹤0.01% 2896
2024
Q1 		$8.15M Sell
1,404,914
-14,615
-1% -$73.2K ﹤0.01% 3078
2023
Q4 		$7.01M Buy
1,419,529
+394,991
+39% +$2.04M ﹤0.01% 3142
2023
Q3 		$5.25M Buy
1,024,538
+32,252
+3% +$190K ﹤0.01% 3225
2023
Q2 		$6.71M Buy
992,286
+930,235
+1,499% +$5.52M ﹤0.01% 3164
2023
Q1 		$384K Buy
+62,051
New +$278K ﹤0.01% 4192

Other funds holding BTMD

3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Vanguard Group's BTMD Position: Q4 2025 in Review

Vanguard Group increased its Biote Corp (BTMD) stake by 1.2% in Q4 2025, buying an estimated $48.6K and bringing the position to 1,444,733 shares worth $3.76M. The position accounts for ﹤0.01% of the portfolio, ranked #3361.

Vanguard Group first reported a position in BTMD in Q1 2023 and has held it in 12 quarters since. The position peaked at $10.3M in Q2 2024. 85 funds tracked by Wall St. Rank hold BTMD as of Q4 2025.

  • Vanguard Group held 1,444,733 shares of Biote Corp worth $3.76M as of Q4 2025.
  • Vanguard Group bought 17,782 Biote Corp shares in Q4 2025, an estimated $48.6K.
  • Biote Corp made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3361 holding.
  • Vanguard Group first reported a position in Biote Corp in Q1 2023 and has held it in 12 quarters since.
  • Vanguard Group's Biote Corp position peaked at $10.3M in Q2 2024.
  • 85 funds tracked by Wall St. Rank held Biote Corp as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.